BACKGROUND: Diabetes mellitus increases the risk of incident colorectal cancer, but it is less clear if pre-existing diabetes mellitus influences mortality outcomes, recurrence risk, and/or treatment-related complications in persons with colorectal cancer. METHODS: We performed a systematic review and meta-analysis comparing colorectal cancer mortality outcomes, cancer recurrence, and treatment-related complications in persons with and without diabetes mellitus. We searched MEDLINE and EMBASE through October 1, 2008, including hand-searching references of qualifying articles. We included studies in English that evaluated diabetes mellitus and cancer treatment outcomes, prognosis, and/or mortality. The initial search identified 8,208 titles, of which 15 articles met inclusion criteria. Each article was abstracted by one author using a standardized form and re-reviewed by another author for accuracy. Authors graded quality based on pre-determined criteria. RESULTS: We found significantly increased short-term perioperative mortality in persons with diabetes mellitus. In the meta-analysis of long-term mortality, persons with diabetes mellitus had a 32% increase in all-cause mortality compared to those without diabetes mellitus (95% CI: 1.24, 1.41). Although data on other outcomes are limited, available studies suggest that pre-existing diabetes mellitus predicts increased risk of some post-operative complications as well as 5-year cancer recurrence. In contrast, there is little evidence that diabetes confers increased risk for long-term cancer-specific mortality. CONCLUSIONS: Patients with colorectal cancer and pre-existing diabetes mellitus have an increased risk of short- and long-term mortality. Future research should determine whether improvements in prevention and treatment of diabetes mellitus will improve outcomes for colorectal cancer patients.
BACKGROUND:Diabetes mellitus increases the risk of incident colorectal cancer, but it is less clear if pre-existing diabetes mellitus influences mortality outcomes, recurrence risk, and/or treatment-related complications in persons with colorectal cancer. METHODS: We performed a systematic review and meta-analysis comparing colorectal cancer mortality outcomes, cancer recurrence, and treatment-related complications in persons with and without diabetes mellitus. We searched MEDLINE and EMBASE through October 1, 2008, including hand-searching references of qualifying articles. We included studies in English that evaluated diabetes mellitus and cancer treatment outcomes, prognosis, and/or mortality. The initial search identified 8,208 titles, of which 15 articles met inclusion criteria. Each article was abstracted by one author using a standardized form and re-reviewed by another author for accuracy. Authors graded quality based on pre-determined criteria. RESULTS: We found significantly increased short-term perioperative mortality in persons with diabetes mellitus. In the meta-analysis of long-term mortality, persons with diabetes mellitus had a 32% increase in all-cause mortality compared to those without diabetes mellitus (95% CI: 1.24, 1.41). Although data on other outcomes are limited, available studies suggest that pre-existing diabetes mellitus predicts increased risk of some post-operative complications as well as 5-year cancer recurrence. In contrast, there is little evidence that diabetes confers increased risk for long-term cancer-specific mortality. CONCLUSIONS:Patients with colorectal cancer and pre-existing diabetes mellitus have an increased risk of short- and long-term mortality. Future research should determine whether improvements in prevention and treatment of diabetes mellitus will improve outcomes for colorectal cancerpatients.
Authors: Nicole Annette Shonka; James R Anderson; Amit W Panwalkar; Elizabeth C Reed; Preston D Steen; Apar Kishor Ganti Journal: Med Oncol Date: 2006 Impact factor: 3.064
Authors: Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke Journal: J Clin Epidemiol Date: 2008-04 Impact factor: 6.437
Authors: Cary P Gross; Zhenchao Guo; Gail J McAvay; Heather G Allore; Mary Young; Mary E Tinetti Journal: J Am Geriatr Soc Date: 2006-12 Impact factor: 5.562
Authors: Lonneke V van de Poll-Franse; Saskia Houterman; Maryska L G Janssen-Heijnen; Marcus W Dercksen; Jan Willem W Coebergh; Harm R Haak Journal: Int J Cancer Date: 2007-05-01 Impact factor: 7.396
Authors: A S Caudle; H J Kim; J E Tepper; B H O'Neil; L A Lange; R M Goldberg; S A Bernard; B F Calvo; M O Meyers Journal: Ann Surg Oncol Date: 2008-04-17 Impact factor: 5.344
Authors: Maryska L G Janssen-Heijnen; Huub A A M Maas; Saskia Houterman; Valery E P P Lemmens; Harm J T Rutten; Jan Willem W Coebergh Journal: Eur J Cancer Date: 2007-08-02 Impact factor: 9.162
Authors: Hiroki Yuhara; Craig Steinmaus; Stephanie E Cohen; Douglas A Corley; Yoshihiro Tei; Patricia A Buffler Journal: Am J Gastroenterol Date: 2011-09-13 Impact factor: 10.864
Authors: Sander de Kort; Mariëlle We Bouwens; Matty P Weijenberg; Maryska Lg Janssen-Heijnen; Adriaan P de Bruïne; Robert Riedl; Ad Am Masclee; Silvia Sanduleanu Journal: United European Gastroenterol J Date: 2016-08-09 Impact factor: 4.623
Authors: Pauline A J Vissers; Floortje Mols; Melissa S Y Thong; Frans Pouwer; Gerard Vreugdenhil; Lonneke V van de Poll-Franse Journal: J Cancer Surviv Date: 2015-02-03 Impact factor: 4.442
Authors: A Zarzavadjian Le Bian; C Denet; N Tabchouri; H Levard; R Besson; T Perniceni; R Costi; P Wind; D Fuks; B Gayet Journal: Tech Coloproctol Date: 2018-03-14 Impact factor: 3.781